Lloyd W. Klein
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lloyd W. Klein has a total of 286 co-authors. Here are the top co-authors by number of shared publications:
H. Vernon Anderson
Cardiology Division University of Texas Health Science Center Houston Texas USA
8 shared publicationsWarren Laskey
University of New Mexico School of Medicine
6 shared publications- Alexander M. Norbash
Boston University School of Medicine, Boston, Massachusetts
5 shared publications David Haines
5 shared publicationsDonald L. Miller
Uniformed Services University of the Health Sciences
5 shared publicationsJames A. Goldstein
5 shared publications
Latest Publications
- 16 September 2026
- Published by Wolters Kluwer Health in Cardiology in Review
The Ischemia–Plaque Paradox: A Mechanistic Framework for Chronic Coronary Syndromes
Percutaneous coronary intervention relieves angina in chronic coronary syndromes, yet contemporary randomized trials have not shown that relieving ischemia reduces death or myocardial infarction when added to optimal medical therapy. This discordance requires a mechanistic reevaluation. Inducible ischemia identifies obstructive coronary disease and the likelihood of angina but does not reliably identify plaques that will rupture. Fractional flow reserve-guided percutaneous intervention reduces urgent revascularization without reducing death or infarction. Most spontaneous infarctions arise from lesions that were not severely obstructive before rupture. Coronary artery bypass grafting reduces spontaneous infarction in complex multivessel and left main disease, plausibly through more complete revascularization and through placement of grafts distal to long diseased segments that preserve perfusion if proximal plaque rupture occurs. Advances in intracoronary imaging and coronary computed tomography angiography can identify high-risk plaque features, but trials of focal treatment of non-flow-limiting vulnerable plaques have not shown benefit. Modern medical therapy with high-intensity lipid lowering, icosapent ethyl in selected patients, anti-inflammatory approaches, and therapies for diabetes and chronic kidney disease has lowered overall event rates. Chronic coronary syndromes comprise 2 overlapping but distinct pathophysiological mechanisms. Flow-limiting stenoses cause angina and are effectively treated by percutaneous coronary intervention. Plaque instability causes infarction and is modified by systemic therapy. Bypass surgery in selected patients with complex coronary anatomy addresses both mechanisms by relieving flow limitation and protecting myocardium against future plaque events.
- 16 September 2026
- Published by Wolters Kluwer Health in Cardiology in Review
The Ischemia–Plaque Paradox: A Mechanistic Framework for Chronic Coronary Syndromes
Percutaneous coronary intervention relieves angina in chronic coronary syndromes, yet contemporary randomized trials have not shown that relieving ischemia reduces death or myocardial infarction when added to optimal medical therapy. This discordance requires a mechanistic reevaluation. Inducible ischemia identifies obstructive coronary disease and the likelihood of angina but does not reliably identify plaques that will rupture. Fractional flow reserve-guided percutaneous intervention reduces urgent revascularization without reducing death or infarction. Most spontaneous infarctions arise from lesions that were not severely obstructive before rupture. Coronary artery bypass grafting reduces spontaneous infarction in complex multivessel and left main disease, plausibly through more complete revascularization and through placement of grafts distal to long diseased segments that preserve perfusion if proximal plaque rupture occurs. Advances in intracoronary imaging and coronary computed tomography angiography can identify high-risk plaque features, but trials of focal treatment of non-flow-limiting vulnerable plaques have not shown benefit. Modern medical therapy with high-intensity lipid lowering, icosapent ethyl in selected patients, anti-inflammatory approaches, and therapies for diabetes and chronic kidney disease has lowered overall event rates. Chronic coronary syndromes comprise 2 overlapping but distinct pathophysiological mechanisms. Flow-limiting stenoses cause angina and are effectively treated by percutaneous coronary intervention. Plaque instability causes infarction and is modified by systemic therapy. Bypass surgery in selected patients with complex coronary anatomy addresses both mechanisms by relieving flow limitation and protecting myocardium against future plaque events.
- Open Access
- 16 July 2026
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 27 (7)
Challenges Facing Contemporary Interventional Cardiology
- 16 July 2026
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 27 (7)
Open AccessChallenges Facing Contemporary Interventional Cardiology
- 8 December 2025
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 18 (23) , 2941-2942
Beyond the Cath Lab
- 8 December 2025
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 18 (23) , 2941-2942
Beyond the Cath Lab
- Open Access
- 5 December 2024
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 25 (12) , 430
Functional Coronary Revascularization: A Valuable Underutilized Diagnostic Approach
- 5 December 2024
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 25 (12) , 430
Open AccessFunctional Coronary Revascularization: A Valuable Underutilized Diagnostic Approach
- Open Access
- 20 February 2024
- Published by Elsevier in JACC: Asia
- Vol. 4 (4) , 332-334
Attuning Percutaneous Coronary Interventional Quality Metrics and Practice Modification
- 20 February 2024
- Published by Elsevier in JACC: Asia
- Vol. 4 (4) , 332-334
Open AccessAttuning Percutaneous Coronary Interventional Quality Metrics and Practice Modification
- Open Access
- 5 February 2024
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 25 (2) , 58
Assessing Quality in Interventional Practice: Identifying Meaningful and Actionable Metrics
Interventional cardiologists should insist on quality assessment techniques that indisputably reflect the merit of care delivered. Only measurable outcomes and metrics that are modifiable should be identified and collected. An evaluation process should be adopted that genuinely appraises clinical practice, incorporating appropriate benchmarks for comparison.
- 5 February 2024
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 25 (2) , 58
Open AccessAssessing Quality in Interventional Practice: Identifying Meaningful and Actionable Metrics
Interventional cardiologists should insist on quality assessment techniques that indisputably reflect the merit of care delivered. Only measurable outcomes and metrics that are modifiable should be identified and collected. An evaluation process should be adopted that genuinely appraises clinical practice, incorporating appropriate benchmarks for comparison.
- 2 November 2023
- Published by Elsevier in The American Journal of Cardiology
- Vol. 210, 315-316
Ticagrelor Versus Clopidogrel for Acute Coronary Syndrome: Have Things Changed?
- 2 November 2023
- Published by Elsevier in The American Journal of Cardiology
- Vol. 210, 315-316
Ticagrelor Versus Clopidogrel for Acute Coronary Syndrome: Have Things Changed?
- Open Access
- 11 August 2023
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 24 (8) , 232
Shared Decision-Making: The More the Patient Knows, the Better the Decision that Is Made
- 11 August 2023
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 24 (8) , 232
Open AccessShared Decision-Making: The More the Patient Knows, the Better the Decision that Is Made
- Open Access
- 29 June 2023
- Published by European Medical Group in EMJ Interventional Cardiology
- Vol. 11 (1) , 49-52
30-Day Mortality Is a Flawed Quality Indicator for Coronary Interventions: Why Interventionalists Should Insist on Better Metrics
The accurate appraisal of operator and programmatic quality of percutaneous coronary interventions (PCI) is a fundamental principle of...
- 29 June 2023
- Published by European Medical Group in EMJ Interventional Cardiology
- Vol. 11 (1) , 49-52
Open Access30-Day Mortality Is a Flawed Quality Indicator for Coronary Interventions: Why Interventionalists Should Insist on Better Metrics
The accurate appraisal of operator and programmatic quality of percutaneous coronary interventions (PCI) is a fundamental principle of...